Caissa Capital Management ltd. - May 4, 2023 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
10%+ Owner
Signature
Cambyz Golestaneh, Title: Director
Stock symbol
AVTX
Transactions as of
May 4, 2023
Transactions value $
$69,365
Form type
4
Date filed
5/8/2023, 04:10 PM
Previous filing
Apr 27, 2023
Next filing
May 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $41.9K +15K +1.14% $2.79* 1.33M May 4, 2023 See Footnote (1) F1, F2
transaction AVTX Common Stock Purchase $14.4K +5K +0.38% $2.88* 1.34M May 5, 2023 See Footnote (1) F1, F3
transaction AVTX Common Stock Purchase $13.1K +5K +0.37% $2.62* 1.34M May 8, 2023 See Footnote (1) F1, F4
holding AVTX Common Stock 182K May 4, 2023 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.58 to $2.85, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.85 to $2.9, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.575 to $2.68, inclusive.
F5 These shares are directly owned by Mr. Golestaneh in his personal capacity.